• SENSEX 81,583.30
    -212.85 (--0.26%)
  • BANKNIFTY 55,714.15
    -230.75 (--0.41%)
  • Vishal Mega Mart
    129.95 134.50(%)
  • Reliance Industr
    1,425.80 1,115.55(%)
  • Infosys
    1,647.70 2,006.80(%)
  • Sterlite Tech.
    119.00 119.00(%)
  • HDFC Bank
    1,919.55 1,588.50(%)
  • Varun Beverages
    469.50 419.40(%)
  • ICICI Bank
    1,417.60 1,101.00(%)
  • TCS
    3,522.30 4,585.90(%)
  • Happiest Minds
    674.00 955.00(%)
  • Mazagon Dock
    3,342.85 3,778.00(%)
  • Garden Reach Sh.
    3,205.00 3,528.00(%)
  • Bharti Airtel
    1,847.50 1,373.05(%)
  • M & M
    2,993.70 2,360.45(%)
  • Kotak Mah. Bank
    2,129.90 1,679.10(%)
  • Tata Motors
    672.00 542.55(%)
  • Cochin Shipyard
    2,244.10 2,977.10(%)
  • Hind. Unilever
    2,334.10 3,034.50(%)
  • Sun Pharma.Inds.
    1,641.40 1,461.40(%)
  • St Bk of India
    790.75 679.65(%)
  • HCL Technologies
    1,738.00 2,011.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

NGL Fine Chem Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 4558.0
  • ISIN : INE887E01022
1,018.30 -21 (-1.99%)
  • As on 17 Jun 2025 (EOD)

  • Today’s Low

    1,018.30

  • Today’s High

    1,030.00

  • Open

    1,030.00

  • Perv Close

    1,039.00

  • 52W Low

    957.00

  • 52W High

    2,777.95

Key Indicators

  • P/E(TTM)

    34.71

  • Mar.Cap (₹Cr.)

    629.31

  • Div & Yield %

    0.00

  • Book Value(₹)

    452.44

  • Debt-Equity Ratio

    -1.99

  • AGM Date

    17-Jun-2025

  • EPS

    29.34

  • P/E Ratio

    34.71

Financials Ratios

  • Debt-Equity Ratio

    0.14

  • Mar.Cap (₹Cr.)

    629.31

  • RONW (%)

    17.03

  • ROCE (%)

    20.16

Score Board

  • Equity (₹ in Cr.)

    3.09

  • BV (₹)

    452.40

  • Sales( ₹ in Cr.)

    359.29

  • NP (in Cr.)

    18.13

  • NP Var(%)

    -53.0

  • Div%

    0.0

  • CPS (₹)

    44.30

  • EPS (₹)

    29.30

  • Traded Value (₹ in Lakhs)

    640.25

  • 52 Week High

    2,777.95

  • 52 Week Low

    957.00

  • Price BSE

    1036.0

  • Price NSE

    1,039.00

  • Market Capital( in Cr.)

    640.25

  • P/C Ratio

    23.40

  • P/E Ratio

    35.30

  • Price Vs.BV

    29.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 328.97 275.05 318.67 258.18 152.18 153.17
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 328.97 275.05 318.67 258.18 152.18 153.17
Other Income 15.90 7.61 12.64 8.55 3.34 4.12
Stock Adjustments 12.06 -23.29 22.03 -1.86 5.39 1.27
Total Income 356.93 259.37 353.34 264.87 160.91 158.56
EXPENDITURE :            
Raw Materials 169.05 118.84 172.92 102.77 71.46 65.29
Power and Fuel Cost 18.60 15.45 14.47 9.27 9.75 8.71
Employee Cost 41.32 34.25 33.05 27.24 23.81 21.16
Other Manufacturing Expenses 47.44 37.17 41.21 26.49 18.50 15.32
Selling and Administration Expenses 14.51 11.24 8.56 11.52 7.94 10.22
Miscellaneous Expenses 5.34 6.09 4.57 1.98 5.19 1.45
Employee Benefit Expenses 41.32 34.25 33.05 27.24 23.81 21.16
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 296.27 223.05 274.77 179.27 136.66 122.15
Operating Profit 60.66 36.33 78.56 85.59 24.24 36.42
Interest 1.80 1.83 1.91 2.20 2.62 2.55
Gross Profit 58.86 34.50 76.65 83.39 21.62 33.87
Depreciation 8.15 7.90 7.67 7.39 7.27 6.30
Profit Before Tax 50.71 26.60 68.98 76.00 14.35 27.57
Current Tax 11.41 7.21 17.15 19.07 4.94 8.02
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.78 -0.73 -0.42 1.46 -1.19 -0.58
Reported Net Profit 38.52 20.12 52.25 55.47 10.60 20.13
Extraordinary Items 0.00 0.00 0.00 0.00 -1.49 0.00
Adjusted Net Profit 38.52 20.12 52.25 55.47 12.09 20.13
Adjustment below Net Profit -0.15 -0.08 -0.05 -0.14 -0.44 -0.05
P & L Balance brought forward 220.22 201.27 150.15 95.91 86.82 66.74
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 1.08 1.08 1.08 1.08 1.08 0.00
P & L Balance carried down 257.51 220.22 201.27 150.15 95.91 86.82
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 35.00 35.00 35.00 35.00 35.00 35.00
Dividend Per Share(Rs) 1.75 1.75 1.75 1.75 1.75 1.75
Earnings Per Share-Unit Curr 62.35 32.57 84.57 89.79 17.16 32.58
Earnings Per Share(Adj)-Unit Curr 62.35 32.57 84.57 89.79 17.16 32.58
Book Value 425.39 365.04 334.36 251.62 163.81 149.11
Book Value(Adj)-Unit Curr 425.39 365.04 334.36 251.62 163.81 149.11

Shareholding Pattern

  • Promoter Group

    72.74%

  • Public Share Holding

    27.26%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 517,871 8.38 517,871 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 3,975,775 64.35 3,975,775 4
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 4,493,646 72.74 4,493,646 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 62 0.00 62 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 62 0.00 62 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 124 0.00 124 3
2] Non Institution
Bodies Corporate 95,963 1.55 87,463 96
Clearing Members 8,738 0.14 8,738 11
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 70,878 1.15 70,878 413
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 98,931 1.60 98,931 276
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 106,745 1.73 106,745 2
Individuals holding nominal share capital up to Rs. 1 lakh 1,298,791 21.02 1,108,044 13,568
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1,000 0.02 1,000 2
Others 0 0.00 0 0
Sub Total 1,684,254 27.26 1,484,707 14,378
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 6,178,024 100.00 5,978,477 14,386

Company Background

NGL Fine Chem LtdPharmaceuticals - Indian - Bulk Drugs

  • NGL Fine Chem Ltd
  • BSE Code : 4558.0
  • ISIN : INE887E01022

  • Incorporation Year

    1981

  • Registered Office

    301 E Square Subhash Road
    Vile Parle (East), Mumbai,
    Maharashtra-400057

  • Telephone

    +91-22-2663 6450

  • FAX

  • Chairman

    Dhananjay Mungale

  • Managing Director

    Rahul J Nachane

  • Company Secretary

    Pallavi Pednekar

  • Auditor

    Manek & Associates

  • Face Value

    5

  • Listing

    NSE

  • Registrar

    Purva Sharegistry (India) Pvt
    Shiv Shakti Indust,
    Unit No 9 Lower Pare,7 B J R Boricha Marg
    Mumbai - Mumbai-400011

NGL Fine Chem Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
NGL Fine Chem 1,018.30 344.87 328.97 34.71 18.73
Abbott India 31,803.35 6,097.18 5,848.91 47.78 44.71
Astrazeneca Phar 10,081.60 1,330.33 1,295.53 217.75 33.26
P & G Health Ltd 5,907.05 1,166.89 1,151.26 39.04 39.76
Glaxosmi. Pharma 3,252.30 3,866.05 3,723.49 59.95 58.72
Cipla 1,503.50 17,645.00 16,574.34 23.54 20.10
Amrutanjan Healt 708.25 437.58 421.23 40.29 20.84
Guj. Themis Bio. 337.05 174.19 169.82 75.23 44.82
Fermenta Biotec. 334.25 315.24 307.09 14.55 4.10
Bliss GVS Pharma 141.95 638.96 605.46 21.67 11.19
Ambalal Sarabhai 36.76 11.70 3.81 34.04 1.92